Curated News Summary
FDA approves Moderna’s mRNA-based vaccine for the flu
Why This Matters
Key context: The shot, named mFlusiva, is intended for adults age 50 or older. Moderna said late Wednesday that it expects some of its new version to be available soon at select retailers. This development from globalnews.ca highlights ongoing changes in the sector.
The shot, named mFlusiva, is intended for adults age 50 or older. Moderna said late Wednesday that it expects some of its new version to be available soon at select retailers.
Curation & Context
This page summarizes a public news report from globalnews.ca. Global News Hub provides the "Why This Matters" takeaway using editorial insights and AI curation to give readers rapid, high-value context before they click through to read the full article.